| |
|
|
|
AzurRx BioPharma Inc.  
|
|
1.73 -0.03 (-0.02%) |
12-13 16:00 |
|
Open: |
1.71 |
Pre close: |
1.76 |
Target:
|
2.61
|
|
High: |
1.85 |
Low: |
1.709 |
Resistance:
|
2.24
2.58
|
|
Volume: |
38,138 |
Market Cap: |
29M |
Support:
|
1.69
1.41
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.77
 |
MACD |
MACD(12,26):
|
-0.15 |
|
MA(20): |
2.00 |
Signal(12,26,9): |
-0.13 |
|
MA(100): |
2.39 |
Stochastic Oscillator |
%K(14,3):
|
8.26 |
|
MA(250): |
2.77 |
%D(3): |
10.80 |
|
Average Volume(K) |
3-Month: |
10650
|
52-Week |
High:
|
4.08 |
|
10-Days: |
6124 |
Low: |
1.69 |
|
RSI |
RSI(14):
|
33.50 |
Change(%): |
-41.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.570 |
Return on Equity (ttm) |
-288.1 |
Shares Out. (M) |
16.94 |
|
EPS Est. Current Year |
-0.850 |
Return on Assets (ttm) |
-155.6 |
Shares Float (M) |
16.10 |
|
EPS Est. Next Year |
-0.670 |
PEG Ratio |
0.00 |
% Held by Insiders |
6.70 |
|
EPS Est. Next Quarter |
-0.160 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
21.00 |
|
Forward EPS |
-0.640 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
5.700 |
EBITDA (p.s.) |
-0.150 |
P/E |
-3.04 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.30 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-10.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-6.77 |
P/CF |
-2.93 |
|
|
|
|
|
|
